Showing 321-330 of 1478 results for "".
- gel-e Receives US FDA Clearance to Expand its Bandage Product Line for Rx, OTC Usehttps://practicaldermatology.com/news/gel-e-receives-us-fda-clearance-to-expand-its-bandage-product-line-for-rx-otc-use/2457951/The U.S. Food and Drug Administration (FDA) has cleared gel-e Inc.’s adhesive bandage for prescription (Rx) and over-the-counter (OTC) use. This 510(k) clearance expands the Company's label to include the ma
- Promius Pharma Employees Fundraise for Hurricane Victimshttps://practicaldermatology.com/news/promius-pharma-employees-fundraise-for-hurricane-victims/2457974/Promius Pharma LLC's employees raised $12,715 to support American Red Cross relief efforts to assist those affected by the recent hurricanes. Additionally, Promius' parent company Dr. Reddy's Laboratories matched this donation for a combined contribution
- FDA Approves Stelara for Treatment of Adolescents with Moderate To Severe Plaque Psoriasishttps://practicaldermatology.com/news/fda-approves-stelara-for-treatment-of-adolescents-with-moderate-to-severe-plaque-psoriasis/2458010/The FDA approved an expanded indication for Janssen Biotech, Inc.'s Stelara (ustekinumab) for the treatment of adolescents (12 years of age or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Today's approval marks a significant mile
- Environmental Groups Sue FDA to Take Formaldehyde Out of Salonshttps://practicaldermatology.com/news/environmental-groups-sue-fda-to-take-formaldehyde-out-of-salons/2458096/The Environmental Working Group (EWG) and Women’s Voices for the Earth (WVE) are suing the Food and Drug Administration (FDA) because of the group’s failure to act on dangerous hair straighteners that contain unsafe levels of formaldehyde and pose a significant health hazard to consum
- Histogen's Growth Factor Technology Now Part of Allergan's Skin Care Linehttps://practicaldermatology.com/news/histogens-growth-factor-technology-now-part-of-allergan-skin-care-line/2458111/Histogen’s growth factor technology will be marketed as part of Allergan's skin care line within its recently acquired Regenica® Advanced Rejuvenation System. The Regenica line is based on multipotent CCM Complex (Cell Conditioned Media) which comprises active growth factors
- Foamix Pharmaceuticals Appoints David Domzalski as CEOhttps://practicaldermatology.com/news/foamix-pharmaceuticals-appoints-david-domzalski-as-ceo/2458137/Foamix Pharmaceuticals Ltd.'s Board of Directors has named David Domzalski Chief Executive Officer of the company effective immediately. Mr. Domzalski currently serves as President of Foamix's US subsidiary. He succeeds Dr. Dov
- Leo Pharma Vet Named New COO for DermaRitehttps://practicaldermatology.com/news/leo-pharma-vet-named-new-coo-for-dermarite/2458157/Barbara J. Osborne is DermaRite Industries’s new Chief Commercial Officer. In her role, Ms. Osborne will be responsible for driving the company's sales and commercialization efforts. She recently served as the U.S. Division President
- Maria Carell Named New CEO of Revision Skincare LLC, Goodier Cosmetics LLChttps://practicaldermatology.com/news/maria-carell-named-new-ceo-of-revision-skincare-llc-goodier-cosmetics-llc/2458223/Maria Carell is the new CEO of Revision Skincare® LLC and Goodier Cosmetics LLC. Ms. Carell's appointment follows the retirement of John Muller, the company's founder. Mr. Muller will retain hi
- Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategyhttps://practicaldermatology.com/news/allergan-names-daphne-karydas-as-senior-vice-president-of-global-investor-relations-strategy/2458224/Daphne Karydas is Allergan’s new Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017. In this role, Ms. Karydas will lead the Company's engagement with the investment community, and will work with
- Obagi Medical Products Collaborates with Suzan Obagi, MD and Nextcell Medical to Introduce New Linehttps://practicaldermatology.com/news/obagi-medical-products-collaborates-with-suzan-obagi-md-and-nextcell-medical-to-introduce-new-line/2458274/Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary Obagi Medical Products collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD’s line of skin care products throughout the United States. Established in 2013 with cosmetic